Related Experiment Video
Updated: Nov 3, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Effects of Salvia miltiorrhiza extract on lung adenocarcinoma
Huixiang Tian1,2, Yueqin Li3, Jie Mei2
1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Abstract:
Lung adenocarcinoma is the most common subtype of non-small cell lung carcinoma. Tanshinone I is an important fat-soluble component in the extract of Salvia miltiorrhiza that has been reported to inhibit lung adenocarcinoma cell proliferation. However, no studies have clearly demonstrated changes in lung adenocarcinoma gene expression and signaling pathway enrichment following Tanshinone I treatment. And it remains unclear whether salvianolate has an effect on lung adenocarcinoma. The present study downloaded the GSE9315 dataset from the Gene Expression Omnibus database to identify differentially expressed genes (DEGs) and the underlying signaling pathways involved after Tanshinone I administration in the lung adenocarcinoma cell line CL1-5. The results revealed that there were 28 and 102 DEGs in the low dosage group (0.01 and 0.10 µg/ml Tanshinone I) and medium dosage groups (1 and 10 µg/ml Tanshinone I), respectively. In the low dosage group, DEGs were mainly enriched in 'positive regulation of T-helper cell differentiation' and 'protein complex'. In the medium dosage group, 102 DEGs were enriched in 'MAPK cascade' and 'extracellular exosome'. Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated enrichment of both groups in the PI3K-Akt signaling pathway. Furthermore, there were nine overlapping DEGs [ADP ribosylation factor-interacting protein 2, chemokine (C-X-C motif) ligand 6, SH2 domain-containing adaptor protein B, Src homology 2 domain-containing transforming protein1, collagen type VI α1 chain, elastin, integrin subunit α, endoplasmic reticulum mannosyl-oligosaccharide 1,2-α-mannosidase and sterile α motif domain-containing 9 like] between the two groups, which serve to be potential targets for the treatment of lung adenocarcinoma. The present study also investigated the possible effects of salvianolate on lung adenocarcinoma in vivo using nude mouse xenograft models injected with the A549 cell line. The data revealed that salvianolate not only suppressed lung adenocarcinoma tumor growth of in nude mice, but also downregulated the expression levels of ATP7A and ATP7B, which are important proteins in the tumorigenesis and chemotherapy of lung adenocarcinoma. The present study provided evidence for the potential use of Salvia miltiorrhiza extract for treating lung adenocarcinomas in the clinic.
Insights
Tanshinone I from Salvia miltiorrhiza inhibits lung adenocarcinoma cell proliferation. This study identified key gene expression changes and signaling pathways, including PI3K-Akt, and showed salvianolate suppressed tumor growth in vivo.
Area of Science:
- Oncology
- Pharmacology
- Genomics
Background:
- Lung adenocarcinoma is a prevalent non-small cell lung carcinoma subtype.
- Tanshinone I, a Salvia miltiorrhiza component, shows potential in inhibiting lung adenocarcinoma cell proliferation.
- Gene expression and signaling pathway alterations following Tanshinone I treatment remain underexplored.
Purpose of the Study:
- To investigate gene expression and signaling pathway changes in lung adenocarcinoma cells treated with Tanshinone I.
- To identify potential therapeutic targets for lung adenocarcinoma.
- To evaluate the in vivo efficacy of salvianolate in suppressing lung adenocarcinoma growth.
Main Methods:
- Gene Expression Omnibus (GEO) dataset GSE9315 was analyzed to identify differentially expressed genes (DEGs) and enriched pathways.
- Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed.
- Nude mouse xenograft models were used to assess the in vivo effects of salvianolate.
Main Results:
- Tanshinone I treatment resulted in 28 DEGs in low-dose and 102 DEGs in medium-dose groups, enriched in pathways like 'positive regulation of T-helper cell differentiation' and 'MAPK cascade'.
- The PI3K-Akt signaling pathway was significantly enriched in both dosage groups.
- Salvianolate suppressed lung adenocarcinoma tumor growth in vivo and downregulated ATP7A and ATP7B expression.
Conclusions:
- Tanshinone I and salvianolate demonstrate therapeutic potential for lung adenocarcinoma.
- Nine overlapping DEGs were identified as potential therapeutic targets.
- Salvia miltiorrhiza extract warrants further investigation for clinical application in treating lung adenocarcinomas.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023